To be specific, Zhang and coworkers366 prepared a tumor‐penetrating neotype neutrophil cytopharmaceutical (NEs@STING‐Mal‐NP) that conjugated liposomal STING agonists on the surface of neutrophils, inheriting the merits of neutrophils such as proactive tumor vascular extravasation and tissue penetration, significantly boosting the tumor penetration of STING agonists. Here, STING1 is linked to neoplasm.